PT904081E - Suspensoes aquosas de esteres de acidos gordos de 9-hidroxirisperidona - Google Patents

Suspensoes aquosas de esteres de acidos gordos de 9-hidroxirisperidona

Info

Publication number: PT904081E
Authority: PT; Portugal
Prior art keywords: aquos; suspensions; fatty acids; acids esters; hydroxyrisperidone fatty
Prior art date: 1996-05-20

Application number

PT97923912T

Other languages

English (en)

Inventor

Roger Carolus August Embrechis

Marc Karel Jozef Francois

Herman Karel Borghijs

Johan Monbaliu

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-20

Filing date

1997-05-12

Publication date

2002-04-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8224016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT904081(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-05-12 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2002-04-29 Publication of PT904081E publication Critical patent/PT904081E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

PT97923912T 1996-05-20 1997-05-12 Suspensoes aquosas de esteres de acidos gordos de 9-hidroxirisperidona PT904081E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP96201429		1996-05-20

Publications (1)

Publication Number	Publication Date
PT904081E true PT904081E (pt)	2002-04-29

Family

ID=8224016

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT97923912T PT904081E (pt)	1996-05-20	1997-05-12	Suspensoes aquosas de esteres de acidos gordos de 9-hidroxirisperidona

Country Status (37)

Country	Link
US (1)	US6077843A (pt)
EP (1)	EP0904081B1 (pt)
JP (1)	JP3274687B2 (pt)
KR (1)	KR100358373B1 (pt)
CN (1)	CN1093762C (pt)
AR (1)	AR007194A1 (pt)
AT (1)	ATE208619T1 (pt)
AU (1)	AU715572B2 (pt)
BG (1)	BG62684B1 (pt)
BR (1)	BR9706824B8 (pt)
CA (1)	CA2236691C (pt)
CY (2)	CY2270B1 (pt)
CZ (1)	CZ291284B6 (pt)
DE (2)	DE69708284T2 (pt)
DK (1)	DK0904081T3 (pt)
EA (1)	EA000536B1 (pt)
EE (1)	EE03594B1 (pt)
ES (1)	ES2167745T3 (pt)
FR (1)	FR11C0035I2 (pt)
HR (1)	HRP970276B1 (pt)
HU (2)	HU224025B1 (pt)
ID (1)	ID16927A (pt)
IL (1)	IL124551A (pt)
LU (1)	LU91842I2 (pt)
MX (1)	MX9804816A (pt)
MY (1)	MY126302A (pt)
NO (2)	NO315931B1 (pt)
NZ (1)	NZ330369A (pt)
PL (1)	PL188309B1 (pt)
PT (1)	PT904081E (pt)
SI (1)	SI0904081T1 (pt)
SK (1)	SK284013B6 (pt)
TR (1)	TR199800923T2 (pt)
TW (1)	TW487572B (pt)
UA (1)	UA61898C2 (pt)
WO (1)	WO1997044039A1 (pt)
ZA (1)	ZA974331B (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA72189C2 (uk) *	1997-11-17	2005-02-15	Янссен Фармацевтика Н.В.	Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
ATE265846T1 (de) *	1998-02-25	2004-05-15	Abbott Lab	Butorphanol enthaltende formulierungen mit verzögerter freisetzung
AU5489299A (en) *	1998-08-18	2000-03-14	Sepracor, Inc.	Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
EP1169024B1 (en)	1999-03-31	2005-12-21	Janssen Pharmaceutica N.V.	Pregelatinized starch in a controlled release formulation
US6495164B1 (en)	2000-05-25	2002-12-17	Alkermes Controlled Therapeutics, Inc. I	Preparation of injectable suspensions having improved injectability
EP1317434A4 (en) *	2000-08-14	2005-06-22	Teva Pharma	PREPARATION OF RISPERIDONE
US7666445B2 (en) *	2000-10-20	2010-02-23	The Trustees Of The University Of Pennsylvania	Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
GB0216416D0 (en) *	2002-07-15	2002-08-21	Novartis Ag	Organic compounds
US20050232995A1 (en) *	2002-07-29	2005-10-20	Yam Nyomi V	Methods and dosage forms for controlled delivery of paliperidone and risperidone
CA2494234C (en) *	2002-07-29	2009-10-27	Alza Corporation	Methods and dosage forms for controlled delivery of paliperidone
GB0322994D0 (en) *	2003-10-01	2003-11-05	Novartis Ag	Organic compounds
CA2543242C (en)	2003-10-23	2015-04-14	Otsuka Pharmaceutical Co., Ltd.	Controlled release sterile freeze-dried aripiprazole formulation and injectable formulation thereof
US8329203B2 (en) *	2004-01-12	2012-12-11	The Trustees Of The University Of Pennsylvania	Drug-containing implants and methods of use thereof
AU2005206143B2 (en) *	2004-01-12	2010-12-16	The Trustees Of The University Of Pennsylvania	Long-term delivery formulations and methods of use thereof
US8221778B2 (en)	2005-01-12	2012-07-17	The Trustees Of The University Of Pennsylvania	Drug-containing implants and methods of use thereof
ES2245252B1 (es) *	2004-06-15	2007-03-01	Farmalider, S.A.	Solucion acuosa de risperidona para administracion oral.
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
US20080214808A1 (en)	2005-04-25	2008-09-04	Thomas Frederik Ernestine Spittaels	Preparation of Aseptic 3-[2-[4-((6-Fluoro-1,2-Benzisoxazol-3-Yl)-1-Piperidinyl]-6,7,8,9-Tetrahydro-9-Hydroxy-2-Methyl-4H-Pyrido[1,2-a]Pyrimidin-4-One Palmitate Ester
PL116330U1 (en)	2005-10-31	2007-04-02	Alza Corp	Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
MX2009001114A (es)	2006-08-09	2009-02-10	Intarcia Therapeutics Inc	Sistemas de suministro osmotico y ensambles de piston.
KR101244185B1 (ko) *	2007-04-19	2013-03-25	유씬 리	정신 장애 치료용 신규 화합물, 그의 제조 방법 및 용도
CN104000779A (zh)	2007-04-23	2014-08-27	精达制药公司	促胰岛素释放肽的混悬制剂及其应用
US20090076035A1 (en) *	2007-09-15	2009-03-19	Protia, Llc	Deuterium-enriched paliperidone
HUE053904T2 (hu)	2007-12-19	2021-07-28	Janssen Pharmaceutica Nv	Hosszan tartó hatású injektálható paliperidon-észterekkel kapcsolatos adagolási rendek
WO2009089076A2 (en) *	2008-01-10	2009-07-16	Teva Pharmaceutical Industries Ltd.	Processes for the preparation and purification of paliperidone palmitate
CA2726861C (en)	2008-02-13	2014-05-27	Intarcia Therapeutics, Inc.	Devices, formulations, and methods for delivery of multiple beneficial agents
BRPI0918904B8 (pt)	2008-09-04	2021-05-25	Amylin Pharmaceuticals Inc	formulação pré-misturada fabricada para injeção, seu uso e kit compreendendo a mesma
DK2462246T3 (da)	2009-09-28	2017-11-06	Intarcia Therapeutics Inc	Hurtig etablering og/eller afslutning af væsentlig steady-state-lægemiddelafgivelse
AU2010313290A1 (en)	2009-10-30	2012-05-17	Janssen Pharmaceutica Nv	Dosing regimen associated with long-acting injectable paliperidone esters
US20120259116A1 (en) *	2009-12-17	2012-10-11	Rajiv Kumar	Novel Process for the Preparation of Paliperidone
TWI577377B (zh)	2010-09-16	2017-04-11	Ｖｉｉｖ醫療保健公司	醫藥組合物
EP2629775A4 (en)	2010-10-18	2014-06-11	Dainippon Sumitomo Pharma Co	INJECTABLE FORMULATION WITH DELAYED RELEASE
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
ES2587527T3 (es) *	2011-05-31	2016-10-25	RAMAMOHAN RAO, Davuluri	Preparación de 3-[2-[4-((6-fluoro-1,2-bencisoxazol-3-il)-l-piperidinil)-6,7,8,9-tetrahidro-9-hidroxi-2-metil-4H-pirido[1,2 a]-primidin-4-ona (paliperidona) y palmitato de paliperidona
WO2013046225A2 (en) *	2011-08-10	2013-04-04	Glenmark Generics Limited	Process for the preparation of paliperidone palmitate
CN102993200B (zh) *	2011-09-10	2016-02-03	鲁翠涛	帕潘立酮氨基酸酯及其制备方法
US10154988B2 (en)	2012-11-14	2018-12-18	The Johns Hopkins University	Methods and compositions for treating schizophrenia
US10525057B2 (en)	2013-09-24	2020-01-07	Otsuka Pharmaceutical Co., Ltd.	Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016164218A1 (en)	2015-04-07	2016-10-13	Janssen Pharmaceuticals, Inc.	Dosing regimen for missed doses for long-acting injectable paliperidone esters
US10925639B2 (en)	2015-06-03	2021-02-23	Intarcia Therapeutics, Inc.	Implant placement and removal systems
MA53353A (fr)	2016-05-16	2021-06-09	Intarcia Therapeutics Inc	Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
KR20190104039A (ko)	2017-01-03	2019-09-05	인타르시아 세라퓨틱스 인코포레이티드	Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
AU2021386450B2 (en)	2020-11-30	2024-03-21	Janssen Pharmaceutica Nv	Dosing regimens associated with extended release paliperidone injectable formulations
SMT202400075T1 (it)	2020-11-30	2024-03-13	Janssen Pharmaceutica Nv	Regimi di dosaggio associati con formulazioni iniettabili di paliperidone a rilascio prolungato
MX2023006369A (es)	2020-11-30	2023-08-09	Janssen Pharmaceutica Nv	Metodos para asegurar resuspension de formulaciones de palmitato de paliperidona.
JP2023551009A (ja)	2020-11-30	2023-12-06	ヤンセンファーマシューティカエヌ．ベー．	持続放出パリペリドン注射可能製剤に関連する投与レジメン
HUP2100259A1 (hu)	2021-07-07	2023-01-28	Richter Gedeon Nyrt	Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények
WO2023021008A1 (en)	2021-08-20	2023-02-23	Janssen Pharmaceutica Nv	Dosing regimens associated with extended release paliperidone injectable formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2000786C (en) *	1988-11-07	1999-01-26	Cornelus G. M. Janssen	3-piperidinyl-1,2-benzisoxazoles
US5158952A (en) *	1988-11-07	1992-10-27	Janssen Pharmaceutica N.V.	3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
US5254556A (en) *	1988-11-07	1993-10-19	Janssen Pharmaceutica N.V.	3-piperidinyl-1,2-benzisoxazoles
TW376319B (en) *	1993-04-28	1999-12-11	Janssen Pharmaceutica Nv	Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
AU694147B2 (en) *	1993-11-19	1998-07-16	Alkermes, Inc.	Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5650173A (en) *	1993-11-19	1997-07-22	Alkermes Controlled Therapeutics Inc. Ii	Preparation of biodegradable microparticles containing a biologically active agent
EP2275089A1 (en) *	1993-11-19	2011-01-19	Alkermes Controlled Therapeutics, Inc.	Preparation of biodegradable microparticles containing a biologically active agent
PT833820E (pt) *	1995-06-06	2001-07-31	Aventis Pharmaceuticals Inc Av	Derivados de benzisoxazol e indazol uteis como agentes antipsicoticos
US5792477A (en) *	1996-05-07	1998-08-11	Alkermes Controlled Therapeutics, Inc. Ii	Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent

1997
- 1997-05-01 TW TW086105768A patent/TW487572B/zh not_active IP Right Cessation
- 1997-05-12 KR KR10-1998-0703629A patent/KR100358373B1/ko not_active Expired - Lifetime
- 1997-05-12 AT AT97923912T patent/ATE208619T1/de active
- 1997-05-12 SK SK620-98A patent/SK284013B6/sk not_active IP Right Cessation
- 1997-05-12 NZ NZ330369A patent/NZ330369A/xx not_active IP Right Cessation
- 1997-05-12 US US09/180,659 patent/US6077843A/en not_active Expired - Lifetime
- 1997-05-12 CN CN97191494A patent/CN1093762C/zh not_active Expired - Lifetime
- 1997-05-12 DE DE69708284T patent/DE69708284T2/de not_active Expired - Lifetime
- 1997-05-12 IL IL12455197A patent/IL124551A/xx not_active IP Right Cessation
- 1997-05-12 DE DE201112100027 patent/DE122011100027I1/de active Pending
- 1997-05-12 TR TR1998/00923T patent/TR199800923T2/xx unknown
- 1997-05-12 PT PT97923912T patent/PT904081E/pt unknown
- 1997-05-12 ES ES97923912T patent/ES2167745T3/es not_active Expired - Lifetime
- 1997-05-12 EP EP97923912A patent/EP0904081B1/en not_active Expired - Lifetime
- 1997-05-12 JP JP54150097A patent/JP3274687B2/ja not_active Expired - Lifetime
- 1997-05-12 AU AU29559/97A patent/AU715572B2/en not_active Expired
- 1997-05-12 WO PCT/EP1997/002504 patent/WO1997044039A1/en not_active Ceased
- 1997-05-12 EE EE9800136A patent/EE03594B1/xx active Protection Beyond IP Right Term
- 1997-05-12 DK DK97923912T patent/DK0904081T3/da active
- 1997-05-12 PL PL97327995A patent/PL188309B1/pl unknown
- 1997-05-12 EA EA199800531A patent/EA000536B1/ru not_active IP Right Cessation
- 1997-05-12 HU HU9901319A patent/HU224025B1/hu active Protection Beyond IP Right Term
- 1997-05-12 BR BRPI9706824-1B8A patent/BR9706824B8/pt not_active IP Right Cessation
- 1997-05-12 CA CA002236691A patent/CA2236691C/en not_active Expired - Lifetime
- 1997-05-12 SI SI9730272T patent/SI0904081T1/xx unknown
- 1997-05-12 CZ CZ19981401A patent/CZ291284B6/cs not_active IP Right Cessation
- 1997-05-19 AR ARP970102112A patent/AR007194A1/es active IP Right Grant
- 1997-05-19 ZA ZA974331A patent/ZA974331B/xx unknown
- 1997-05-19 MY MYPI97002172A patent/MY126302A/en unknown
- 1997-05-19 ID IDP971649A patent/ID16927A/id unknown
- 1997-05-20 HR HR970276A patent/HRP970276B1/xx not_active IP Right Cessation
- 1997-12-05 UA UA98052747A patent/UA61898C2/uk unknown
1998
- 1998-04-30 NO NO19981984A patent/NO315931B1/no not_active IP Right Cessation
- 1998-05-12 BG BG102443A patent/BG62684B1/bg unknown
- 1998-06-15 MX MX9804816A patent/MX9804816A/es unknown
2002
- 2002-04-25 CY CY0200021A patent/CY2270B1/xx unknown
2011
- 2011-07-20 LU LU91842C patent/LU91842I2/fr unknown
- 2011-08-18 HU HUS1100013C patent/HUS1100013I1/hu unknown
- 2011-08-18 CY CY2011011C patent/CY2011011I2/el unknown
- 2011-08-29 NO NO2011015C patent/NO2011015I2/no unknown
- 2011-09-02 FR FR11C0035C patent/FR11C0035I2/fr active Active

Also Published As

Publication number	Publication date
ATE208619T1 (de)	2001-11-15
EA199800531A1 (ru)	1998-12-24
BR9706824B8 (pt)	2015-02-18
HUS1100013I1 (hu)	2017-03-28
HUP9901319A3 (en)	1999-11-29
HU224025B1 (hu)	2005-05-30
US6077843A (en)	2000-06-20
AR007194A1 (es)	1999-10-13
PL188309B1 (pl)	2005-01-31
MX9804816A (es)	1998-10-31
FR11C0035I2 (fr)	2013-08-16
DE69708284D1 (de)	2001-12-20
AU2955997A (en)	1997-12-09
DK0904081T3 (da)	2002-02-25
KR19990067603A (ko)	1999-08-25
AU715572B2 (en)	2000-02-03
ZA974331B (en)	1998-11-19
NO315931B1 (no)	2003-11-17
CZ140198A3 (cs)	1999-04-14
CY2270B1 (en)	2003-07-04
NO981984D0 (no)	1998-04-30
LU91842I2 (fr)	2011-09-20
NO2011015I1 (no)	2011-09-19
CY2011011I1 (el)	2016-12-14
ID16927A (id)	1997-11-20
BG62684B1 (bg)	2000-05-31
IL124551A (en)	2001-08-26
EP0904081A1 (en)	1999-03-31
HUP9901319A2 (hu)	1999-08-30
FR11C0035I1 (pt)	2011-07-10
EP0904081B1 (en)	2001-11-14
KR100358373B1 (ko)	2003-02-11
NO981984L (no)	1998-11-19
PL327995A1 (en)	1999-01-04
EA000536B1 (ru)	1999-10-28
TR199800923T2 (xx)	1999-09-21
CN1093762C (zh)	2002-11-06
TW487572B (en)	2002-05-21
JP3274687B2 (ja)	2002-04-15
CA2236691C (en)	2007-01-02
SK284013B6 (sk)	2004-08-03
SK62098A3 (en)	2000-04-10
WO1997044039A1 (en)	1997-11-27
UA61898C2 (en)	2003-12-15
BG102443A (en)	1999-06-30
CY2011011I2 (el)	2016-12-14
IL124551A0 (en)	1998-12-06
EE9800136A (et)	1998-10-15
CZ291284B6 (cs)	2003-01-15
DE69708284T2 (de)	2002-07-25
HRP970276A2 (en)	1998-04-30
NO2011015I2 (no)	2013-03-11
HRP970276B1 (en)	2002-04-30
EE03594B1 (et)	2002-02-15
MY126302A (en)	2006-09-29
NZ330369A (en)	2000-04-28
ES2167745T3 (es)	2002-05-16
CA2236691A1 (en)	1997-11-27
BR9706824A (pt)	1999-03-23
CN1206347A (zh)	1999-01-27
HK1017852A1 (en)	1999-12-03
JP2000513718A (ja)	2000-10-17
DE122011100027I1 (de)	2011-11-17
SI0904081T1 (en)	2002-04-30

Publication	Publication Date	Title
PT904081E (pt)	2002-04-29	Suspensoes aquosas de esteres de acidos gordos de 9-hidroxirisperidona
PT1033987E (pt)	2003-09-30	Suspensoes aquosas de esteres de 9-hidroxirrisperidona com acidos gordos da ordem dos submicrons
PL331700A1 (en)	1999-08-02	Method of obtaining fatty acid esters
EP0736545A3 (en)	1997-06-18	Ester of dextrin and fatty acids and its use
PT823895E (pt)	2004-11-30	Esteres de acidos gordos como composto bioactivos
HRP20041057A2 (en)	2005-06-30	Method and system for the esterification of fatty acids
ID17964A (id)	1998-02-12	Pembuatan ester surfaktan
EE04281B1 (et)	2004-04-15	8-metoksükinoloonkarboksüülhapete valmistamismeetod
DK0718275T3 (da)	1998-08-10	Kvaternære triethanolaminfedtsyreestere
DE69507006D1 (de)	1999-02-11	Ceramid-3-derivate von einfachungesättigten fettsäuren
FR2722798B1 (fr)	1996-09-13	1procede de production d'acides gras2plantes oleagineuses
GB9620248D0 (en)	1996-11-13	Esters of unsaturated fatty acids
PL332853A1 (en)	1999-10-25	Method of obtaining alpha-alkoxy-alpha-trifluoromethyl-acrylacetic esters and acids
PT854142E (pt)	2003-02-28	Processo para preparacao de esteres de acidos 1-alquilpirazol-5-carboxilicos
GB9705102D0 (en)	1997-04-30	Presentation of fatty acids
DE69515479D1 (de)	2000-04-13	Fettsäureester von verätherten polyalkoholen
AU3645195A (en)	1996-05-06	Modified polyunsaturated fatty acids
GB9403906D0 (en)	1994-04-20	Reduced absorption of fatty acids
PL322156A1 (en)	1999-03-29	Method of obtaining monocarboxylic esters
ATA199097A (de)	1999-12-15	Verfahren zur herstellung von fettsäuremethylester und anlage zur durchführung des verfahrens
GB9317347D0 (en)	1993-10-06	Method of maintaining the level of polyunsaturated fatty acids
PL331949A1 (en)	2000-09-11	Method of obtaining methyl esters of fatty acids
SK2252U (sk)	1999-08-06	Zariadenie na kontinuálnu esterifikáciu mastných kyselín